Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer
Targeting aromatase deprives ER+ breast cancers of estrogens and is an effective therapeutic approach for these tumors. However, drug resistance is an unmet clinical need. Lipidomic analysis of long-term estrogen-deprived (LTED) ER+ breast cancer cells, a model of aromatase inhibitor resistance, revealed enhanced intracellular lipid storage. Functional metabolic analysis showed that lipid droplets together with peroxisomes, which we showed to be enriched and active in the LTED cells, controlled redox homeostasis and conferred metabolic adaptability to the resistant tumors. This reprogramming was controlled by acetyl-CoA-carboxylase-1 (ACC1), whose targeting selectively impaired LTED survival. However, the addition of branched- and very long-chain fatty acids reverted ACC1 inhibition, a process that was mediated by peroxisome function and redox homeostasis. The therapeutic relevance of these findings was validated in aromatase inhibitor-treated patient-derived samples. Last, targeting ACC1 reduced tumor growth of resistant patient-derived xenografts, thus identifying a targetable hub to combat the acquisition of estrogen independence in ER+ breast cancers.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Science translational medicine - 16(2024), 736 vom: 28. Feb., Seite eadf9874 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bacci, Marina [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acetyl-CoA Carboxylase |
---|
Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1126/scitranslmed.adf9874 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369067673 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369067673 | ||
003 | DE-627 | ||
005 | 20240301232756.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1126/scitranslmed.adf9874 |2 doi | |
028 | 5 | 2 | |a pubmed24n1313.xml |
035 | |a (DE-627)NLM369067673 | ||
035 | |a (NLM)38416843 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bacci, Marina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.03.2024 | ||
500 | |a Date Revised 01.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Targeting aromatase deprives ER+ breast cancers of estrogens and is an effective therapeutic approach for these tumors. However, drug resistance is an unmet clinical need. Lipidomic analysis of long-term estrogen-deprived (LTED) ER+ breast cancer cells, a model of aromatase inhibitor resistance, revealed enhanced intracellular lipid storage. Functional metabolic analysis showed that lipid droplets together with peroxisomes, which we showed to be enriched and active in the LTED cells, controlled redox homeostasis and conferred metabolic adaptability to the resistant tumors. This reprogramming was controlled by acetyl-CoA-carboxylase-1 (ACC1), whose targeting selectively impaired LTED survival. However, the addition of branched- and very long-chain fatty acids reverted ACC1 inhibition, a process that was mediated by peroxisome function and redox homeostasis. The therapeutic relevance of these findings was validated in aromatase inhibitor-treated patient-derived samples. Last, targeting ACC1 reduced tumor growth of resistant patient-derived xenografts, thus identifying a targetable hub to combat the acquisition of estrogen independence in ER+ breast cancers | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Aromatase Inhibitors |2 NLM | |
650 | 7 | |a Acetyl-CoA Carboxylase |2 NLM | |
650 | 7 | |a EC 6.4.1.2 |2 NLM | |
650 | 7 | |a Estrogens |2 NLM | |
700 | 1 | |a Lorito, Nicla |e verfasserin |4 aut | |
700 | 1 | |a Smiriglia, Alfredo |e verfasserin |4 aut | |
700 | 1 | |a Subbiani, Angela |e verfasserin |4 aut | |
700 | 1 | |a Bonechi, Francesca |e verfasserin |4 aut | |
700 | 1 | |a Comito, Giuseppina |e verfasserin |4 aut | |
700 | 1 | |a Morriset, Ludivine |e verfasserin |4 aut | |
700 | 1 | |a El Botty, Rania |e verfasserin |4 aut | |
700 | 1 | |a Benelli, Matteo |e verfasserin |4 aut | |
700 | 1 | |a López-Velazco, Joanna I |e verfasserin |4 aut | |
700 | 1 | |a Caffarel, Maria M |e verfasserin |4 aut | |
700 | 1 | |a Urruticoechea, Ander |e verfasserin |4 aut | |
700 | 1 | |a Sflomos, George |e verfasserin |4 aut | |
700 | 1 | |a Malorni, Luca |e verfasserin |4 aut | |
700 | 1 | |a Corsini, Michela |e verfasserin |4 aut | |
700 | 1 | |a Ippolito, Luigi |e verfasserin |4 aut | |
700 | 1 | |a Giannoni, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Meattini, Icro |e verfasserin |4 aut | |
700 | 1 | |a Matafora, Vittoria |e verfasserin |4 aut | |
700 | 1 | |a Havas, Kristina |e verfasserin |4 aut | |
700 | 1 | |a Bachi, Angela |e verfasserin |4 aut | |
700 | 1 | |a Chiarugi, Paola |e verfasserin |4 aut | |
700 | 1 | |a Marangoni, Elisabetta |e verfasserin |4 aut | |
700 | 1 | |a Morandi, Andrea |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Science translational medicine |d 2009 |g 16(2024), 736 vom: 28. Feb., Seite eadf9874 |w (DE-627)NLM195151879 |x 1946-6242 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2024 |g number:736 |g day:28 |g month:02 |g pages:eadf9874 |
856 | 4 | 0 | |u http://dx.doi.org/10.1126/scitranslmed.adf9874 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2024 |e 736 |b 28 |c 02 |h eadf9874 |